Filing Details
- Accession Number:
- 0001179110-13-009580
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-04 14:37:13
- Reporting Period:
- 2013-05-31
- Filing Date:
- 2013-06-04
- Accepted Time:
- 2013-06-04 14:37:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1145460 | Alere Inc. | ALR | In Vitro & In Vivo Diagnostic Substances (2835) | 043565120 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1466092 | Lester Michael Cotton | 3200 Windy Hill Road Suite B-100 Atlanta GA 30339 | Global Pres, Health Mgmt | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-31 | 8,750 | $25.43 | 8,750 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-31 | 8,750 | $25.86 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-05-31 | 8,750 | $0.00 | 8,750 | $25.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-02-28 | 2022-02-28 | No | 4 | M | Direct |
Footnotes
- Represents same day exercise and sale of stock options.
- This derivative security does not have a price.
- The price represents the average purchase price for 23 separate transactions reported on this line. The price of the transactions reported on this line range from $25.85 to $25.88. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.